Write down the diagnostic plan for a patient with history of gastric,h pylori negative, reflux taking voraprazan but still symptomatic and Les pressure low, no dental caries, halitosis, weight normal BMI,no respiratory symptoms and no pain in chest,no HTN and diabetes, mother has diabetes and HTN...no tb or other conditions

Reading File
Finding Sources
Finding Sources
Searching PubMed

vonoprazan refractory GERD diagnosis

Searching the Web

refractory GERD low LES pressure vonoprazan still symptomatic diagnostic workup 2024 2025

Finding Sources
Finding Sources
Finding Sources
Searching PubMed

refractory GERD diagnostic workup esophageal impedance pH manometry

Reading File
Reading File
Reading File
Finding Sources
Finding Sources
I now have sufficient information from the library and current literature to write the full diagnostic plan. Let me compile the comprehensive answer.

Diagnostic Plan: Refractory GERD on Vonoprazan with Low LES Pressure

Clinical Summary

Patient profile: Known gastric/esophageal reflux disease, H. pylori negative, on vonoprazan (potassium-competitive acid blocker / P-CAB), still symptomatic. Low LES (lower esophageal sphincter) pressure confirmed. Normal BMI, no dental caries, halitosis present, no chest pain, no respiratory symptoms, no HTN or diabetes. Family history: mother with diabetes and HTN.
This is a case of refractory GERD on optimized acid suppression - the most important diagnostic challenge is distinguishing between:
  1. True acid breakthrough / persistent pathological reflux despite vonoprazan
  2. Weakly acidic or non-acid (alkaline/bile) reflux
  3. Esophageal hypersensitivity
  4. Functional heartburn (no true reflux)
  5. A structural/motility problem driving the low LES pressure
  6. An alternate or co-existing diagnosis

Step 1 - Confirm Compliance and Optimise Before Further Testing

  • Verify vonoprazan dose: 20 mg once daily for active symptoms (healing dose), taken correctly
  • Rule out medications that further reduce LES pressure: calcium channel blockers, nitrates, theophylline, benzodiazepines, NSAIDs, anticholinergics - ask explicitly
  • Review dietary triggers: fatty foods, chocolate, citrus, carbonated drinks, coffee, alcohol, late meals, lying down after eating
  • Review lifestyle: smoking (nicotine lowers LES pressure), body position in bed (head of bed elevation?)
  • Rule out recent weight gain even within normal BMI range (abdominal adiposity can occur at normal BMI)

Step 2 - Upper Endoscopy (EGD) with Biopsies (First Priority if Not Recently Done)

Indications in this patient:
  • Persistent symptoms despite potent acid suppression
  • Halitosis (raises concern for mucosal disease, bile reflux, gastroparesis)
  • Evaluate for complications and alternate diagnoses
What to look for and biopsy:
FindingSignificance
Erosive esophagitis (grade A-D, LA classification)Confirms acid/reflux injury persisting despite P-CAB
Barrett's esophagus (salmon-colored mucosa)Long-term GERD complication; mandates surveillance
Hiatal herniaLow LES pressure + hiatal hernia = mechanical failure; drives regurgitation independent of acid
Eosinophilic esophagitis (EoE)Rings/furrows/exudates; biopsies show >15 eosinophils/HPF; can mimic GERD and is refractory to acid suppression
Pill-induced or caustic esophagitisDiscrete ulceration
Bile/duodenal refluxBile-stained mucosa, greenish fluid in stomach
Gastric mucosal abnormalityRule out residual gastric pathology
Peptic strictureDysphagia may be subtle
Reference: Goldman-Cecil Medicine - "endoscopy is indicated for cases with persistent symptoms... to exclude eosinophilic esophagitis, pill-induced esophagitis, stricture, Barrett esophagus, and malignancy."

Step 3 - Ambulatory 24-hour pH-Impedance Monitoring (Most Important Functional Test)

This is the gold standard for evaluating refractory symptoms on therapy.
Two scenarios:
A. Off vonoprazan (after 7-14 day washout) - "off therapy" pH study:
  • Use wireless Bravo capsule (48-96 hours) or nasal catheter
  • Determines if there is true pathological acid exposure (DeMeester score, % time pH <4)
  • If normal: favors functional heartburn or hypersensitivity, not true GERD
B. On vonoprazan - "on therapy" pH-impedance study:
  • Combined multichannel intraluminal impedance (MII) + pH catheter
  • Detects both acid and non-acid reflux events
  • Evaluates symptom-reflux association (Symptom Index, Symptom Association Probability)
  • If non-acid reflux episodes are temporally linked to symptoms: weakly acidic or alkaline reflux is driving symptoms - acid suppression alone will not help
Reference: Harrison's 22nd Edition - "Combined esophageal pH and impedance testing using a transnasal catheter while on PPI therapy can define if a patient with persistent or atypical symptoms has esophageal hypersensitivity or regurgitation of nonacidic or weakly acidic fluid."

Step 4 - High-Resolution Esophageal Manometry (HRM)

Directly relevant given the known low LES pressure.
What it evaluates:
  • LES resting pressure (confirm degree and type of hypotension)
  • Transient LES relaxations (TLESRs) - the most common mechanism of reflux even in low LES pressure states
  • Esophageal body motility - ineffective esophageal motility (IEM) is common in GERD and impairs acid clearance
  • Hiatal hernia - manometric identification and sizing
  • Rule out major motor disorders that mimic GERD:
    • Achalasia - can present with regurgitation and be misdiagnosed as GERD (very important to exclude)
    • Hypercontractile esophagus (Jackhammer)
    • Distal esophageal spasm
Reference: Washington Manual - "Esophageal manometry, particularly HRM, may identify motor processes contributing to refractory symptoms." Yamada's Gastroenterology - "Esophageal manometry is useful for detecting major motor disorders or evaluating peristalsis before antireflux surgery."

Step 5 - Gastric Emptying Study (Rule out Gastroparesis)

Why relevant in this patient:
  • Halitosis + refractory symptoms on acid suppression despite H. pylori negativity raises concern
  • Delayed gastric emptying increases gastric distension, raises intragastric pressure, worsens reflux, and can cause regurgitation and halitosis independent of acid
  • 20% of gastroparesis patients have pain predominance rather than nausea/vomiting
Test:
  • 4-hour solid-meal gastric scintigraphy (radiolabeled technetium-99m egg meal) - gold standard
  • Alternative: 13C-octanoate breath test (non-radioactive)
  • Alternative: Wireless motility capsule (SmartPill) - also assesses small bowel/colon transit

Step 6 - Laryngoscopy / ENT Evaluation

Why this patient:
  • Halitosis is present - while gastroparesis and reflux are common causes, laryngopharyngeal reflux (LPR) should be evaluated
  • LPR may persist or worsen even with good esophageal acid control because brief pharyngeal acid exposures are sufficient for laryngeal injury
  • ENT exam: posterior laryngeal erythema, cobblestoning, vocal cord edema (Belafsky Reflux Finding Score)
  • Consider dedicated hypopharyngeal-esophageal multichannel pH-impedance or pharyngeal pH probe (Restech) if LPR is suspected

Step 7 - Rumination Syndrome Assessment

  • Low LES pressure + regurgitation + refractory symptoms on acid suppression are all consistent with rumination syndrome which is commonly misdiagnosed as GERD
  • Diagnostic criteria (Rome IV): recurrent regurgitation of recently ingested food, not preceded by retching, cessation when material becomes acidic
  • Confirmed on HRM: characteristic pattern of intra-abdominal pressure rises immediately post-prandially preceding regurgitation
  • Important because this is behavioural/physiotherapy-managed - not medication-managed

Step 8 - Additional Blood Tests

TestRationale
FBC / CBCExclude anemia from esophagitis/peptic disease
Serum gastrin (fasting)Vonoprazan can elevate gastrin; rule out Zollinger-Ellison syndrome if markedly elevated
Thyroid function (TSH)Hypothyroidism causes gastroparesis and dysmotility mimicking GERD
HbA1c and fasting glucoseFamily history of diabetes; insulin resistance/early diabetes can cause gastroparesis
Calcium, PTHHypercalcemia / hyperparathyroidism causes peptic disease and dysmotility
Serum IgA + tissue transglutaminaseCeliac disease mimics upper GI symptoms
Esophageal eosinophil biopsy resultFrom endoscopy (Step 2)

Diagnostic Algorithm Summary

Refractory symptoms on vonoprazan
              ↓
Step 1: Compliance check + medication/diet/lifestyle review
              ↓
Step 2: Upper endoscopy + biopsies
    → Barrett's? EoE? Hiatal hernia? Bile reflux? Stricture?
              ↓
Step 3: 24h pH-impedance monitoring (on therapy)
    → True acid reflux? Non-acid reflux? Hypersensitivity? Functional heartburn?
              ↓
Step 4: High-resolution esophageal manometry
    → Low LES confirmed? Achalasia excluded? IEM? Rumination pattern?
              ↓
Step 5: Gastric emptying scintigraphy
    → Gastroparesis contributing to reflux/halitosis?
              ↓
Step 6: ENT / laryngoscopy for LPR
              ↓
Step 7: Blood panel (gastrin, thyroid, HbA1c, celiac screen)

Key Diagnoses to Definitively Exclude in This Patient

DiagnosisWhy it fitsKey test
Non-acid / bile refluxLow LES, refractory to acid suppressionpH-impedance on therapy
Esophageal hypersensitivitySymptoms without pathological refluxpH-impedance + symptom correlation
Functional heartburnRome IV criteria; no true refluxpH-impedance off therapy
Hiatal hernia with mechanical refluxLow LES pressure may be partly from herniaHRM + endoscopy
AchalasiaRegurgitation mimics GERD, refractory to all acid suppressantsHRM
Eosinophilic esophagitisRefractory to acid suppression, normal BMI, young patientsEndoscopy + biopsy
GastroparesisHalitosis, worsens reflux, H. pylori negativeGastric emptying scan
LPRHalitosis, throat symptomsENT + pharyngeal pH probe
Rumination syndromeRegurgitation, low LES on manometryHRM + Rome IV criteria
Early diabetes-related dysmotilityStrong family history of diabetesHbA1c, fasting glucose

Note on Vonoprazan Specifically

Vonoprazan (P-CAB) provides stronger, more consistent acid suppression than PPIs by blocking the H⁺/K⁺-ATPase pump in a potassium-competitive manner, with less CYP2C19 dependence. Persistent symptoms on vonoprazan 20 mg are therefore strong evidence that acid alone is not the problem - the diagnostic workup above is essential to identify the true driver.
Recent evidence (PMID 40450492 - Italian GERD Guidelines 2025; PMID 41616396 - GERD in the 21st century, 2026) reinforces the stepwise approach: endoscopy first, then pH-impedance monitoring to phenotype the refractory patient, followed by manometry.

Sources: Harrison's Principles of Internal Medicine 22E, Goldman-Cecil Medicine, Sleisenger & Fordtran's GI and Liver Disease, Yamada's Textbook of Gastroenterology 7e, Washington Manual of Medical Therapeutics, Current Surgical Therapy 14e; supplemented with Italian GERD Guidelines 2025 (PMID 40450492) and GERD 21st Century Review 2026 (PMID 41616396).

How to examine and tell if a child is in pain and which part medically

Reading File
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Searching the Web

pediatric pain assessment tools examination techniques localize pain in children clinical 2024

Reading File
Finding Sources
Finding Sources
Finding Sources
Reading File
Reading File
Reading File
Reading File
Loading Image
Reading File
I now have all the information needed for a comprehensive answer. Let me compile it.

How to Examine and Determine if a Child is in Pain - and Where

Assessing pain in children is one of the most important - and most challenging - skills in pediatric clinical practice. The approach depends entirely on the child's age and developmental stage, because young children cannot verbally report pain the way adults do.

Part 1 - General Signs That a Child Is in Pain

Before applying any formal tool, look for these universal indicators across all ages:

Physiologic (Autonomic) Signs

These appear most strongly in acute pain and may fade with chronic or ongoing pain:
SignWhat to Look For
TachycardiaHeart rate elevated above age-normal
HypertensionBP elevated for age
TachypneaRapid breathing, irregular pattern
Oxygen desaturationSpO2 drop in monitored patients
DiaphoresisSweating unexplained by fever
Pallor or flushingSkin colour change
Dilated pupilsSympathetic activation
Note: Do NOT use vital signs alone as your only pain measure - they lack specificity and sensitivity for pain quantification. (Tintinalli's Emergency Medicine)

Behavioural Signs (Observable in All Ages)

SignDetails
CryingHigh-pitched, persistent, inconsolable cry
Facial grimacingFurrowed brow, quivering chin, clenched jaw, brow bulging, nasolabial deepening
Body posturingGuarding, arching, rigidity, drawing knees to chest
Leg movementKicking, drawing up legs, tensing thighs
RestlessnessShifting, writhing, inability to be still
WithdrawalPulling away when touched in a specific area - a localizing clue
Disturbed sleepPain-related waking, refusal to sleep
InconsolabilityCannot be soothed by parent, toy, or distraction
Protective posturingChild holds or guards a body part
Reduced activityStops playing, becomes very still or limp

Part 2 - Age-Based Assessment with Validated Tools

A. Neonates and Infants (0 - 3 years)

Cannot self-report. Rely entirely on observation.
Neonatal Infant Pain Scale (NIPS) - for preterm and full-term neonates up to 6 weeks:
Category0 Points1 Point2 Points
Facial expressionRelaxedContracted (grimace)-
CryAbsentMumbling/whimperingVigorous/screaming
BreathingRelaxedDifferent from baseline-
ArmsRelaxedFlexed or stretched-
LegsRelaxedFlexed or stretched-
AlertnessSleeping/calmUncomfortable/agitated-
Score >3 = need for analgesia.

FLACC Scale - for infants and children up to 3-4 years old (also used in non-verbal/cognitively impaired patients at any age):
Category012
FaceNo expression or smileOccasional grimace, withdrawn, disinterestedFrequent/constant quivering chin, clenched jaw
LegsNormal or relaxedUneasy, restless, tenseKicking, or drawn up
ActivityLying quietly, normal positionSquirming, shifting, tenseArched, rigid, or jerking
CryNo cryMoans/whimpers, occasional complaintCrying steadily, screams, frequent complaints
ConsolabilityContent, relaxedReassured by touch, hugging, talking; distractibleDifficult to console or comfort
Score 0-10. Score >6 = need for analgesia.
(Harriet Lane Handbook, 23rd Edition; Tintinalli's Emergency Medicine)

B. Preschool Children (3 - 8 years)

Beginning to self-report but need picture-based tools.
Faces Pain Scale - Revised (FPS-R) - usable from age 3:
  • Show child a series of faces ranging from neutral (no pain) to distressed (maximum pain)
  • Child points to the face that matches how they feel
  • Scores range 0 - 10
Wong-Baker FACES Scale - widely used from age 3-4+:
Wong-Baker FACES Pain Rating Scale showing 6 faces from 0 (No Hurt) to 10 (Hurts Worst)
The child simply points to the face that best matches their pain.

C. School-Age and Adolescents (6 - 18 years)

Can use numerical self-report tools.
Numeric Rating Scale (NRS-11):
  • "On a scale of 0 to 10, where 0 is no pain and 10 is the worst pain you can imagine, how much does it hurt?"
  • Valid and reliable from age 6-7 upward
  • No equipment needed
Visual Analog Scale (VAS):
  • A 100 mm horizontal line from "no pain" to "worst pain"
  • Child makes a mark on the line
  • Distance measured in mm = pain score
  • Valid from age 8 upward; sensitive to change with treatment

Age-to-Tool Quick Reference

AgeRecommended Tool(s)
0 - 6 weeks (neonate)NIPS
6 weeks - 3 years (infant/toddler)FLACC Scale
3 - 7 years (preschool)Wong-Baker FACES / FPS-R
6 - 18 years (school age/adolescent)NRS-11, VAS
Any age with cognitive impairmentRevised FLACC (r-FLACC)

Part 3 - How to Localise WHERE the Pain Is

1. Verbal Children (Age 3+) - Ask Directly

Use age-appropriate language:
  • "Show me where it hurts" - let them point or place their own hand
  • "Does it hurt here? What about here?" while touching systematically
  • Use a body map/pain chart - a front-and-back outline of a child's body; ask them to colour or mark where it hurts

2. Non-Verbal/Pre-Verbal Children - Observe and Elicit

TechniqueWhat You DoWhat It Tells You
Systematic palpationGently press each body region in sequence; watch face and handsChild grimaces, pulls away, cries, or goes rigid at the painful area
Watch for guardingObserve spontaneous posturing - which area do they protect or hold?Child keeping hand on belly, ear, leg
Provocation testGently move the suspected area (limb, neck, abdomen)Pain on movement = musculoskeletal or peritoneal
Rebound tendernessIn abdomen: press slowly then release rapidlyRelease pain = peritoneal irritation
PercussionTap body wall gently over different areasPain on percussion pinpoints visceral or bone source
Parent observationAsk parent: "Which part does she hold? What makes it worse?"Invaluable for non-verbal children

3. Regional Examination Clues by Body Area

RegionSigns That Point to That Area
HeadHolding head, pressing temples, photophobia, phonophobia, rocking, refusing to look at light; in infants - high-pitched cry, bulging fontanelle
EarsPulling or tugging at one or both ears, rolling head, crying with jaw movement or lying down
Throat/mouthDrooling, refusing to swallow, pawing at mouth, hoarse cry
ChestGrunting respirations, splinting (holding breath to avoid deep breathing), tachypnea, leaning forward, holding chest wall
AbdomenKnees drawn to chest, rigid or tense abdomen on palpation, guarding (tensing on approach of examiner's hand), rebound tenderness, facial grimace localised to palpation of a specific quadrant, refusal to move
Musculoskeletal / limbNot moving a limb (pseudoparalysis), refusing to weight-bear, crying with passive range of motion, swelling, point tenderness on palpation
Back / spineAbnormal posture, refusal to bend, pain on spinal percussion (vertebral tenderness)
GenitourinaryHolding groin/genitals, crying with urination, distended bladder

4. The Pain Quality Gives Diagnostic Clues

Pain QualityTypeCommon Cause
Sharp, stabbing, well-localisedSomatic (skin, muscle, bone, joint)Fracture, laceration, muscle injury
Deep, dull, crampy, poorly localisedVisceral (organs)Appendicitis, intussusception, renal colic
Burning, shooting, electric, "pins and needles"NeuropathicNerve injury, post-herpetic, neuropathy
Colicky (comes and goes in waves)Visceral / hollow organBowel obstruction, intussusception, biliary/renal colic

Part 4 - Children with Special Needs / Cognitive Impairment

These children are at high risk of undertreated pain because their behavioral responses to pain may be atypical. Key observable categories include:
CategoryExamples
VocalizationCrying, moaning, gasping, sharp intake of breath
Facial reactionGrimacing, squinting, frowning, teeth grinding
InteractionInconsolable, withdrawn, seeking comfort
SleepDisturbed sleep, increased or decreased sleep
Activity/toneRestlessness, startles easily, pulls away when touched, posturing (arching/stiffening)
PhysiologicTachycardia, pallor, sweating, tears
AtypicalBreath-holding, self-injurious behaviour, laughter (paradoxical)
Use the r-FLACC (Revised FLACC) - same scoring 0-10, but parent-individualised to the specific child's pain behaviors.
(Harriet Lane Handbook, 23rd Edition - from Hauer & Houtrow, Pediatrics 2017)

Part 5 - Key Clinical Principles

  1. Reassess after every intervention - pain score should be recorded before and after any treatment, with timing appropriate to the drug's expected onset
  2. Never assume a non-communicating child feels no pain - cognitive disability does not equal absence of pain perception
  3. Parent input is essential - parents know their child's baseline and can identify deviations that clinicians will miss
  4. Physiologic signs alone are insufficient - vital sign changes are non-specific; always combine with behavioral observation
  5. Use the same scale consistently within an institution for serial comparisons
  6. A child who goes very still (not playing, not engaging) may be in MORE pain than one who is crying - profound pain can cause withdrawal rather than distress

Sources: The Harriet Lane Handbook 23rd Edition (Johns Hopkins); Tintinalli's Emergency Medicine 9th Edition; Katzung Basic & Clinical Pharmacology 16th Edition; Cummings Otolaryngology; Canadian Paediatric Society Pain Assessment Guidelines 2024
This is a shared conversation. Sign in to Orris to start your own chat.